🇺🇸 FDA

Company profile · Sponsor

PLIANT

PLIANT THERAPEUTICS, INC.

PLRX · NYSE pharma SOUTH SAN FRANCISCO, CA, USA
Pipeline
6
Drugs
0
Patents
8

Quick answer

PLIANT (PLRX) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker PLRX
Exchange NYSE
Company type pharma
Headquarters SOUTH SAN FRANCISCO, CA, USA
SEC CIK 0001746473

Pipeline (6)

Search pipeline →

  1. Bexotegrast, Placebo matching PLN-74809

    PLIANT

    Idiopathic pulmonary fibrosis (IPF)

    phase 3 small molecule active

    1 trial

  2. PLN-74809

    PLIANT

    Acute Respiratory Distress Syndrome

    phase 2 small molecule terminated

    1 trial

  3. PLN-74809

    PLIANT

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule completed

    4 trials

  4. PLN-74809

    PLIANT

    Primary Sclerosing Cholangitis

    phase 2 small molecule completed

    1 trial

  5. PLN-101095

    PLIANT

    Advanced or Metastatic Solid Tumor

    phase 1 small molecule active

    1 trial

  6. [18F]FP-R01-MG-F2

    PLIANT

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12390463

    Dosage forms and regimens for amino acid compounds

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12134642

    Antibodies binding to α7β1 integrin antibodies and compositions thereof

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11952376

    Substituted amino acids as integrin inhibitors

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11858931

    Amino acid compounds with unbranched linkers and methods of use

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11673887

    N-acyl amino acid compounds and methods of use

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11634418

    Amino acid compounds and methods of use

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11560376

    Amino acid compounds and methods of use

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11419869

    Dosage forms and regimens for amino acid compounds

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is PLIANT?

PLIANT (PLRX) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does PLIANT sponsor?

We track 6 ClinicalTrials.gov-linked programs for PLIANT, including Bexotegrast, Placebo matching PLN-74809 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does PLIANT company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.